诺和锐30治疗初诊2型糖尿病的临床观察(2)
 |
| 第1页 |
参见附件。
[参考文献]
[1]UK prospective diabetes study group. UK prospective diabetes study 16: overview of 6 years' therapy of type Ⅱ diabetes:a progressive disease[J].Diabetes,1995,44(11):1249-1258.
[2]李光伟,宁光,周智广.2 型糖尿病早期胰岛素强化治疗改善胰岛β细胞功能——是现实还是梦想[J].中华内分泌代谢杂志,2006,22(4):309-312.
[3]Dean John D, Morris Andrew D, Wilkinson Peter D, et al. Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes[J].Diabetes Care,2007,30(5):10441.
[4]Garber AJ, Wahlen J, Wahl T, et al. Attainment of glycaemic goal in type 2 diabetes with once, twice or thrice daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)[J]. Diabetes Obes Metab,2006,8(1):58-66.
[5]冯凭,天津地区协作组.2型糖尿病住院患者每日三次诺和锐30注射的血糖控制多中心研究[J].国际内分泌代谢杂志,2007,20:428-429.
[6]Yang WY, Ji QH, Zhu DL, et al. Efficacy and safety of twice daily vs thrice daily injections of biphasic insulin aspart 30 in insulinnaive patients with type 2 diabetes inadequately controlled with OADs[J].Diabetes,2007,51(Suppl 1):2154.
(收稿日期:2009-10-12)
您现在查看是摘要介绍页，详见PDF附件。